Accession | ARO:0000018 |
Synonym(s) | Celiomycin Florimycin Tuberactinomycin B Viocin |
Definition | Viomycin sulfate (Viocin) is an polypeptide antibiotic used in the treatment of tuberculosis. It is produced by the actinomycete Streptomyces puniceus and binds to the bacterial ribosome, inhibiting prokaryotic protein synthesis and certain forms of RNA splicing. |
Drug Class | peptide antibiotic |
Classification | 2 ontology terms | Show |
Parent Term(s) | 1 ontology terms | Show + peptide antibiotic [Drug Class] |
Sub-Term(s) | 6 ontology terms | Show + RNA guanosine binding site targeted_by_antibiotic + ribosomal complex targeted_by_antibiotic + vph confers_resistance_to_antibiotic + Mycobacterium tuberculosis 16S rRNA mutation conferring resistance to viomycin confers_resistance_to_antibiotic + Mycolicibacterium smegmatis 16S rRNA (rrsA) mutation conferring resistance to viomycin confers_resistance_to_antibiotic + Mycolicibacterium smegmatis 16S rRNA (rrsB) mutation conferring resistance to viomycin confers_resistance_to_antibiotic |
Publications | Yamada T, et al. 1978. Nature 275(5679): 460-461. Resistance to viomycin conferred by RNA of either ribosomal subunit. (PMID 211438) |